Pharmaceutical Manufacturing Handbook: Production and

REFERENCES 675
19. Van der Lubben , I. M. , Verhoef , J. C. , Borchard , G. , and Junginger , H. E. ( 2001 ), Chitosan
and its derivatives in mucosal drug and vaccine delivery , Eur. J. Pharm. Sci. , 14 , 201 –
207 .
20. Van der Lubben , I. M. , Kersten , G. , Fretz , M. M. , Beuvery , C. , Verhoef , J. C. , and
Junginger , H. E. ( 2003 ), Chitosan microparticles for mucosal vaccination against diphteria:
Oral and nasal effi cacy studies in mice , Vaccine , 21 , 1400 – 1408 .
21. Kang , M. L. , Kang , S. G. , Jiang , H. - L. , Shin , S. W. , Lee , D. Y. , Ahn , J. - M. , Rayamahji , N. ,
Park , I. - K. , Shin , S. J. , Cho , C. - S. , and Yoo , H. S. ( 2006 ), In vivo induction of mucosal
immune responses by intranasal administration of chitosan microspheres containing
Bordetella bronchiseptica DNT . Eur. J. Pharm. Biopharm. , 63 , 215 – 220 .
22. Huang , J. , Garmise , R. J. , Crowder , T. M. , Mar , K. , Hwang , C. R. , Hickey , A. J. , Mikszta ,
J. A. , and Sullivan , V. J. ( 2004 ), A novel dry powder infl uenza vaccine and intranasal
delivery technology: Induction of systemic and mucosal immune responses in rats ,
Vaccine , 23 , 794 – 801 .
23. Behl , C. R. , Pimplaskar , H. K. , Sileno , A. P. , de Meireles , J. , and Romeo , V. D. ( 1998 ),
Effects of physicochemical properties and other factors on systemic nasal drug delivery ,
Adv. Drug Deliv. Rev. , 29 , 89 – 116 .
24. Genta , I. , Pavanetto , F. , Conti , B. , Giunchedi , P. , and Conte , U. ( 1995 ), Improvement of
dexamethasone dissolution rate from spray - dried chitosan microspheres , S. T. P. Pharm.
Sci. , 5 , 202 – 207 .
25. Gavini , E. , Hegge , A. B. , Rassu , G. , Sanna , V. , Testa , C. , Pirisino , G. , Karlsen , J. , and
Giunchedi , P. ( 2006 ), Nasal administration of carbamazepine using chitosan microspheres:
In vitro/in vivo studies , Int. J. Pharm. , 307 , 9 – 15 .
26. Filipovi ć- Gr či ć,
J. , Perissutti , B. , Moneghini , M. , Voinovich , D. , Martinac , A. , and Jal š enjak ,
I. ( 2003 ), Spray - dried carbamazepine - loaded chitosan and HPMC microspheres: Preparation
and characterisation , J. Pharm. Pharmacol. , 55 , 921 – 931 .
27. Teshima , D. , Yamauchi , A. , Makino , K. , Kataoka , Y. , Arita , Y. , Nawata , H. , and Oishi , R.
( 2002 ), Nasal glucagon delivery using microcrystalline cellulose in healthy volunteers ,
Int. J. Pharm. , 233 , 61 – 66 .
28. Sacchetti , C. , Artusi , M. , Santi , P. , and Colombo , P. ( 2002 ), Caffeine microparticles for
nasal administration obtained by spray drying , Int. J. Pharm. , 242 , 335 – 339 .
29. Kublik , H. , and Vidgren , M. T. ( 1998 ), Nasal delivery systems and their effect on deposition
and absorption , Adv. Drug Deliv. Rev. , 29 , 157 – 177 .
30. Ugwoke , M. I. , Verbeke , N. , and Kinget , R. ( 2001 ), The biopharmaceutical aspects of
nasal mucoadhesive drug delivery , J. Pharm. Pharmacol. , 53 , 3 – 22 .
31. Pringels , E. , Callens , C. , Vervaet , C. , Dumont , F. , Slegers , G. , Foreman , P. , and Remon ,
J. P. ( 2006 ), Infl uence of deposition and spray pattern of nasal powders on insulin bioavailability
, Int. J. Pharm. , 310 , 1 – 7 .
32. Mygind , N. , and Dahl , R. ( 1998 ), Anatomy, physiology and function of the nasal cavities
in health and disease , Adv. Drug Deliv. Rev. , 29 , 3 – 12 .
33. Cornaz , A. - L. , De Ascentis , A. , Colombo , P. , and Buri , P. ( 1996 ), In vitro characteristics
of nicotine microspheres for transnasal delivery , Int. J. Pharm. , 129 , 175 – 183 .
34. Ugwoke , M. I. , Agu , R. U. , Verbeke , N. , and Kinget , R. ( 2005 ), Nasal mucoadhesive drug
delivery: Background, applications, trends and future perspectives , Adv. Drug Deliv. Rev. ,
57 , 1640 – 1665 .
35. Smart , J. D. ( 2005 ), The basics and underlying mechanisms of mucosdhesion , Adv. Drug
Deliv. Rev. , 57 , 1556 – 1568 .
36. Mathiowitz , E. , and Chickering , D. E. ( 1999 ), Defi nitions, mechanisms and theories of
bioadhesion , in Mathiowitz , E. , Chickering , D. E. , and Lehr , C. - M. , Eds., Bioadhesive